Stocktoria
Research Solutions, Inc. RSSS
Research Solutions, Inc. (RSSS) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $48.3M at a 5.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.73 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 1013 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.119 |
| Retained earnings / assets | -0.543 |
| EBIT / assets | 0.054 |
| Equity / liabilities | 0.433 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| RSSS | Research Solutions, Inc. | 5/9 | -1.74 | 27.1 | -1.5% |
| HGBL | Heritage Global Inc. | 5/9 | -3.22 | 11.8 | +12.4% |
| POWW | Outdoor Holding Co | 7/9 | 6.36 | — | +3.5% |
| DVLT | Datavault AI Inc. | 5/9 | 4.3 | — | — |
| CURR | Currenc Group Inc. | 6/9 | -3.93 | — | -18.6% |
| INVU | Investview, Inc. | 3/9 | -14.41 | — | -30.8% |
| MOGU | MOGU Inc. | — | — | — | -6.6% |
About Research Solutions, Inc.
Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.ai and Scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets. The company also offers Article Galaxy and Article Galaxy Scholar, a solution that allows research organizations to load entitlements, including subscriptions, discount, or token packages, and existing library of articles. In addition, it provides Generative AI, a solution to help researchers understand the quality of the articles they are reviewing, speed up the review process, and to understand how various research papers relate to each other. Further, the company offers references solution, enables researchers to organize literature, collaborate with team members, and access collection of scientific content. Additionally, its platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.
FAQ
Is RSSS financially healthy?
Research Solutions, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does RSSS pay a dividend?
No, Research Solutions, Inc. does not currently pay a dividend.
How profitable is RSSS?
In FY2025, Research Solutions, Inc. had a net margin of 5.8% and a return on equity of 13.6%.
Is RSSS overvalued or undervalued?
Research Solutions, Inc. trades at about 23.2× trailing earnings — below its 10-year norm (10-year range 24.4×–189.0×, median 66.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for RSSS?
The average Wall-Street price target for Research Solutions, Inc. is $3.83, about 83.4% above the recent price, from 3 analysts.
Is RSSS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Research Solutions, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone, a P/E of about 27.1×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.